Should I Take Aspirin? The SITA Trial, a randomised controlled trial of a decision aid to support informed choices about taking aspirin to prevent bowel cancer for Australians aged 50 to 70 years

Not Applicable

Completed

• Conditions: Colorectal cancer prevention; Cardiovascular disease prevention; Cancer - Bowel - Back passage (rectum) or large bowel (colon); Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12620001003965
• Lead Sponsor: The University of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-06
• Study Completion: 2021-11-23
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 264

Inclusion Criteria

Eligible patients will be aged 50-70, able to read English and competent to give informed consent.

Exclusion Criteria

People with contraindications to aspirin (e.g. previous peptic ulcer, taking anticoagulants) or those using aspirin regularly will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified